Singapore markets open in 7 hours 52 minutes

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
3.9900+0.0300 (+0.76%)
As of 12:49PM EDT. Market open.
Full screen
Previous close3.9600
Open4.0500
Bid3.9900 x N/A
Ask4.0000 x N/A
Day's range3.8700 - 4.0500
52-week range3.4400 - 9.1000
Volume18,500
Avg. volume68,722
Market cap142.134M
Beta (5Y monthly)1.13
PE ratio (TTM)N/A
EPS (TTM)-1.1700
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.45
  • CNW Group

    Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology to optimize drug delivery for applications with significant unmet need, today announced that the Company will present two abstracts at the upcoming Osteoarthritis Research Society International ("OARSI") World Congress 2024. The meeting is being held in Vienna, Austria from April 18-21, 2024.

  • PR Newswire

    Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology to optimize drug delivery for applications with significant unmet need, announced today that senior management will deliver a corporate presentation at the 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto.

  • CNW Group

    Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology to optimize drug delivery for applications with significant unmet need, announced today that trading of the Company's common shares will begin today, April 5, 2024, on the Nasdaq Capital Market ("Nasdaq"), under the ticker symbol "EPRX".